NO2011024I2 - Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen - Google Patents

Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen

Info

Publication number: NO2011024I2
Authority: NO; Norway
Prior art keywords: deposited; virus; strain; spdv; ecacc
Prior art date: 1994-10-18

Application number

NO2011024C

Other languages

English (en)

Other versions

NO2011024I1 (no

Original Assignee

Intervet Int Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-18

Filing date

2011-10-28

Publication date

2015-09-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2011024(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-10-18 Priority claimed from GB9420956A external-priority patent/GB9420956D0/en

1995-04-28 Priority claimed from GBGB9508704.5A external-priority patent/GB9508704D0/en

1995-05-10 Priority claimed from GBGB9509425.6A external-priority patent/GB9509425D0/en

2011-10-28 Application filed by Intervet Int Bv filed Critical Intervet Int Bv

2011-11-14 Publication of NO2011024I1 publication Critical patent/NO2011024I1/no

2015-09-07 Publication of NO2011024I2 publication Critical patent/NO2011024I2/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Urology & Nephrology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
General Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Oncology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Tropical Medicine & Parasitology (AREA)
Cell Biology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Gastroenterology & Hepatology (AREA)

NO2011024C 1994-10-18 2011-10-28 Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen NO2011024I2 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9420956A GB9420956D0 (en)	1994-10-18	1994-10-18	Virus
GBGB9508704.5A GB9508704D0 (en)	1995-04-28	1995-04-28	Virus
GBGB9509425.6A GB9509425D0 (en)	1995-05-10	1995-05-10	"Virus"

Publications (2)

Publication Number	Publication Date
NO2011024I1 NO2011024I1 (no)	2011-11-14
NO2011024I2 true NO2011024I2 (no)	2015-09-07

Family

ID=27267435

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO19954135A NO317547B1 (no)	1994-10-18	1995-10-17	Fiskebukspyttkjertel-sykdomsvirus, fremgangsmate for diagnostisering av sykdom og for isolering av virus, samt vaksine og diagnostisk reagens.
NO2011024C NO2011024I2 (no)	1994-10-18	2011-10-28	Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO19954135A NO317547B1 (no)	1994-10-18	1995-10-17	Fiskebukspyttkjertel-sykdomsvirus, fremgangsmate for diagnostisering av sykdom og for isolering av virus, samt vaksine og diagnostisk reagens.

Country Status (9)

Country	Link
US (2)	US5939073A (no)
EP (1)	EP0712926B1 (no)
JP (1)	JP3676449B2 (no)
AT (1)	ATE251667T1 (no)
CA (1)	CA2160764C (no)
DE (1)	DE69531891D1 (no)
DK (1)	DK0712926T3 (no)
NO (2)	NO317547B1 (no)
PT (1)	PT712926E (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0626635B1 (en) *	1993-05-24	2003-03-05	Sun Microsystems, Inc.	Improved graphical user interface with method for interfacing to remote devices
US6719980B1 (en)	1998-05-08	2004-04-13	Akzo Nobel Nv	Structural proteins of fish pancreatic disease virus and uses thereof
US20030108901A1 (en) *	2001-07-17	2003-06-12	Kibenge Frederick S.B.	Serological test for ISAV in fish
WO2003013597A1 (en) *	2001-08-10	2003-02-20	University Of Maryland Biotechnology Institute	Sub-unit vaccine for infectious pancreatic necrosis virus
AU2004279610B2 (en)	2003-10-07	2010-02-25	Ingrid Dheur	Piscirickettsia salmonis antigens and use thereof
DK179025B1 (da)	2005-09-16	2017-08-28	Intervet Int Bv	Fiskevaccine
JP2010514412A (ja)	2006-12-22	2010-05-06	ソリューシオネスバイオテクノロジカスイノヴァシオンリミターダ	Ｄｎａ魚ワクチン
EP2231698B9 (en)	2007-12-19	2014-10-29	Intervet International BV	Vaccine antigens from piscirickettsia salmonis
NO333242B1 (no) *	2008-02-08	2013-04-15	Pharmaq As	Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus
NO346489B1 (no) *	2008-02-08	2022-09-05	Pharmaq As	Anvendelse av inaktivert SAV i fremstilling av en vaksine.
US9139618B2 (en)	2010-12-29	2015-09-22	Intervet Inc.	Salmonid alphavirus protein E2
WO2012130723A1 (en)	2011-03-25	2012-10-04	Intervet International B.V.	Salmonid alphavirus vaccine
EP3037823A1 (en)	2014-12-22	2016-06-29	BioMar Group A/S	Method for determining pathological tissue damage and diagnosing infectious disease in fish
KR102163242B1 (ko) *	2018-06-05	2020-10-08	전남대학교산학협력단	무지개송어의 면역글로불린 m에 특이적인 단클론항체 및 이의 용도
NO344938B1 (en)	2018-12-13	2020-07-20	Patogen As	Pancreas Disease Virus Markers
CN113122510A (zh) *	2021-04-12	2021-07-16	中国水产科学研究院黑龙江水产研究所	一种传染性造血器官坏死病疫苗及其病毒在胖头鱥肌肉细胞上扩增的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5165925A (en) *	1989-05-02	1992-11-24	State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University	Vaccine for immunizing fish against infectious pancreatic necrosis virus

1995
- 1995-10-13 DK DK95202771T patent/DK0712926T3/da active
- 1995-10-13 DE DE69531891T patent/DE69531891D1/de not_active Expired - Lifetime
- 1995-10-13 AT AT95202771T patent/ATE251667T1/de active
- 1995-10-13 EP EP95202771A patent/EP0712926B1/en not_active Expired - Lifetime
- 1995-10-13 PT PT95202771T patent/PT712926E/pt unknown
- 1995-10-17 CA CA002160764A patent/CA2160764C/en not_active Expired - Lifetime
- 1995-10-17 NO NO19954135A patent/NO317547B1/no not_active IP Right Cessation
- 1995-10-18 US US08/544,681 patent/US5939073A/en not_active Expired - Lifetime
- 1995-10-18 JP JP27017295A patent/JP3676449B2/ja not_active Expired - Lifetime
1997
- 1997-05-08 US US08/854,057 patent/US5914260A/en not_active Expired - Lifetime
2011
- 2011-10-28 NO NO2011024C patent/NO2011024I2/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE251667T1 (de)	2003-10-15
NO954135L (no)	1996-04-19
CA2160764A1 (en)	1996-04-19
DK0712926T3 (da)	2004-02-09
US5939073A (en)	1999-08-17
JPH08228770A (ja)	1996-09-10
JP3676449B2 (ja)	2005-07-27
EP0712926A2 (en)	1996-05-22
NO317547B1 (no)	2004-11-15
CA2160764C (en)	2002-09-03
PT712926E (pt)	2004-02-27
DE69531891D1 (de)	2003-11-13
US5914260A (en)	1999-06-22
NO2011024I1 (no)	2011-11-14
NO954135D0 (no)	1995-10-17
EP0712926A3 (no)	1996-07-03
EP0712926B1 (en)	2003-10-08

Publication	Publication Date	Title
NO2011024I2 (no)	2015-09-07	Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen
Hulst et al.	2001	Interaction of classical swine fever virus with membrane-associated heparan sulfate: role for virus replication in vivo and virulence
Hulst et al.	2000	Passage of classical swine fever virus in cultured swine kidney cells selects virus variants that bind to heparan sulfate due to a single amino acid change in envelope protein Erns
Brownlie	1990	Pathogenesis of mucosal disease and molecular aspects of bovine virus diarrhoea virus
DE69637914D1 (de)	2009-06-10	Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
DK0784483T3 (da)	2001-03-26	Præparat indeholdende et rekombinant virus, der udtrykker et antigen, og et rekombinant virus, der udtrykker et immunstimul
EA200401405A1 (ru)	2005-04-28	Модифицированный осповакцинный вирус анкара для вакцинации новорожденных
CA2102036A1 (en)	1994-05-01	Vaccines raising an immunological response against the disease caused by the iowa strain of porcine reproductive and respiratory syndrome virus
NO329875B1 (no)	2011-01-17	Isolert DNA-sekvens som koder for svinereproduktive- og respiratoriske syndromvirus (PRRSV), en sammensetning omfattende polypeptidene kodet av denne, en sammensetning for indusering av antistoffer mot PRRSV, anvendelse av sammensetning for fremstilling av vaksine og fremgangsmate for a skille PRRSV-stamme ISU-55 fra andre PRRSV-stammer.
DE3853422D1 (de)	1995-04-27	HIV-3-Retrovirus und seine Verwendung.
NZ503039A (en)	2002-09-27	Recombinant porcine adenovirus vector
ATE241014T2 (de)	2003-06-15	Hiv-2 varianten
CA2186044A1 (en)	1995-09-28	Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
JP3602841B2 (ja)	2004-12-15	弱毒型のウシウィルス性下痢性ウィルス
CA2248182A1 (en)	1997-09-04	Porcine reproductive and respiratory syndrome vaccine
ES467557A1 (es)	1979-08-01	Un procedimiento para la preparacion de una nueva vacuna queprotege a las aves ponedoras de huevos contra la enfermedad del descenso de la produccion de huevos.
Morales et al.	2004	Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins
PT868522E (pt)	2003-08-29	Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao
Amadori et al.	1995	Role of a distinct population of bovine γδ T cells in the immune response to viral agents
JP4664072B2 (ja)	2011-04-06	Ｃ及び／又はｅ１タンパク質を発現しないペスチウイルスのレプリコン及びワクチンに使用できる前記レプリコンを含む感染性ウイルス粒子
WO2010135054A2 (en)	2010-11-25	Mutations in a toll-like receptor motif in the ns4b of classical swine fever virus skin brescia influences virulence in swine
RU2006118106A (ru)	2008-01-10	Вектор химерного аденовируса типа 5/типа 35
SE9600436D0 (sv)	1996-02-06	Vaccine against hantavirus
Ceschia et al.	1996	Phenotypical and serotypical variability of Yersinia ruckeri Italian strains.

Legal Events

Date	Code	Title	Description
2015-09-07	MK1K	Patent expired